24th

October

2024

Real World Evidence Community Forum
12 days to go!
Register Now

30th

October

2024

October Webinar Wednesday
18 days to go!
Register Now

10th

November

2024

EU Connect 2024
29 days to go!
Register Now

30th

October

2024

October Webinar Wednesday
18 days to go!
Register Now
  1. Home
  2. /
  3. Academia Meet
  4. /
  5. CUSAT

Cochin University of Science and Technology (CUSAT) | September 2023

Following a memorable visit to Cochin University of Science and Technology (CUSAT) on 20 September 2023, the PHUSE Academia Meet initiative continues to make waves. Anil Kumar, Senior Director at ICON Clinical Research, and Mahesh Divakaran, Associate Lead in Clinical Data Analytics at GENPRO Research, took centre stage in a stimulating session that left a profound impact on both students and faculty members. The visit revolved around the vast realm of clinical research and the myriad career opportunities it presents.

Anil Kumar, a distinguished industry expert, provided valuable insights into the field, delving into the current job landscape, growth potential, and emerging trends. Mahesh Divakaran, with his expertise in clinical data analytics, added depth to the conversation, sharing his wealth of knowledge and experience.

The interactive session fostered a spirit of curiosity among the students and faculty. This translated into numerous requests for follow-up sessions from students eager to explore the industry and from educators interested in aligning their curricula with industry requirements.

Our visit to Cochin University of Science and Technology is a testament to the dedication of the PHUSE Academia Meet initiative in bridging the gap between academia and the pharmaceutical industry. We are enthusiastic about the journey ahead and remain steadfast in our mission to empower students with the knowledge and skills they need for a prosperous career in the pharmaceutical sector. We thank you for your unwavering support and look forward to continuing this exciting journey of collaboration.